Immunotherapy has led to a paradigm shift in the treatment of several cancers. There have
been significant efforts to identify biomarkers that can predict response and toxicities related …

Simple Summary Despite the emerging success of immunotherapy in non-small-cell lung
cancer (NSCLC), it remains clinically important to better identify patients who are likely to …

Despite the efficacy of immunotherapy in non-small cell lung cancer (NSCLC), the majority
of the patients experience relapse with limited subsequent treatment options. Preclinical …

Immunotherapy of cancer in general, and colorectal cancer specifically, is currently one of
the most exciting and active areas of research in cancer therapeutics. Previously confined to …

Colorectal cancer (CRC) is one of the most common malignant diseases. Generally, stoma
construction is performed following surgery for the resection of the primary tumor in patients …